Drawing for REMD

USPTO serial 88599442

REMD

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
HOPKINS, SARAH COLLEEN
Law office
TMO LAW OFFICE 123 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REMD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sherry Flax

Sherry Flax SAUL EWING ARNSTEIN & LEHR LLP500 E PRATT STSUITE 900BALTIMORE, MD 21202

Goods and services

ClassDescriptionStatusFirst use
003Non-medicated cleansers for personal use, namely, soaps, lotions, bath bombs, and creams containing CBD oil with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Non-medicated skin care preparations, namely, soaps, lotions, bath bombs, and creams containing CBD oil with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Non-medicated herbal body care products, namely, soaps, lotions, bath bombs, and creams containing CBD oil with a delta-9 THC concentration of not more than 0.3% on a dry weight basisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 8, 2022MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
Jul 8, 2022ABN1ABANDONMENT - EXPRESS MAILED—
Jul 7, 2022EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jun 14, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 14, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 14, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 14, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 14, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 9, 2022DOCKASSIGNED TO EXAMINER—
Jan 10, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 10, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 10, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Dec 11, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 11, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Dec 11, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 11, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Dec 11, 2019CNSLSUSPENSION LETTER WRITTEN—
Dec 5, 2019DOCKASSIGNED TO EXAMINER—
Sep 21, 2019DOCKASSIGNED TO EXAMINER—
Sep 12, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 3, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance